A Study to Evaluate the Effect of Food on the Pharmacokinetic Characteristics and Safety Profile of KH607 in Healthy Chinese Participants

Phase 1 Not yet recruiting 16 enrolled Chengdu Kanghong Pharmaceutical Co., Ltd.

RandomizedCrossoverOpen-labelTreatment

Summary

This study is a randomized, open-label, 2-period, 2-sequence, crossover food-effect study designed to evaluate the effect of a high-fat meal on the pharmacokinetics of a single oral dose of KH607 tablets in healthy participants, as well as to assess the safety of a single oral dose of KH607 tablets administered under fasting and fed conditions in healthy participants.

Timeline

Start: 2026-06
Primary completion: 2026-07
Completion: 2026-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	KH607	Unknown	—	Oral

Indications

No indication recorded.